The subjects were randomly assigned to receive subcutaneous semaglutide at doses of 0.5 mg or comparator medications (placebo, sitagliptin, exenatide extended-release, or insulin glargine)
The important caveat: those studies used specialized pharmaceutical carrier systems, not standard consumer adhesive patches
[cited 2026 Feb 11];28 Suppl:500S-516S
Legal representation is vital for navigating these complex cases
Even though GLP-1 medications suppress appetite, its important to consume adequate protein, vitamins, minerals, and overall calories to support your health
PlexusDx offers a Precision Peptide Genetic Test that identifies common variants in these peptide-metabolism genes, potentially adding context to a provider conversation about whether standard GLP-1 dosing, microdose protocols, or combination therapies may align better with an individual's genetic profile